↓ Skip to main content

Dove Medical Press

AZGP1 Up-Regulation is a Potential Target for Andrographolide Reversing Radioresistance of Colorectal Cancer

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, December 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter
1 X user
wikipedia
1 Wikipedia page

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
5 Mendeley
Title
AZGP1 Up-Regulation is a Potential Target for Andrographolide Reversing Radioresistance of Colorectal Cancer
Published in
Pharmacogenomics and Personalized Medicine, December 2022
DOI 10.2147/pgpm.s360147
Pubmed ID
Authors

Ye-Ying Fang, Jin-Mei Huang, Jia-Ying Wen, Jian-Di Li, Jin-Hai Shen, Da-Tong Zeng, Yan-Fang Pan, He-Qing Huang, Zhi-Guang Huang, Li-Min Liu, Gang Chen

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 20%
Student > Ph. D. Student 1 20%
Researcher 1 20%
Unknown 2 40%
Readers by discipline Count As %
Unspecified 1 20%
Pharmacology, Toxicology and Pharmaceutical Science 1 20%
Unknown 3 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2024.
All research outputs
#8,517,505
of 26,020,829 outputs
Outputs from Pharmacogenomics and Personalized Medicine
#110
of 374 outputs
Outputs of similar age
#161,587
of 494,716 outputs
Outputs of similar age from Pharmacogenomics and Personalized Medicine
#2
of 11 outputs
Altmetric has tracked 26,020,829 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 374 research outputs from this source. They receive a mean Attention Score of 4.6. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 494,716 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.